GB Virus Type C/Hepatitis G Virus

Jack T. Stapleton

doi:10.1055/s-2003-39943

Seminars in Liver Disease, Inhaltsverzeichnis

Semin Liver Dis 2003; 23(2): 137-148
DOI: 10.1055/s-2003-39943

GB Virus Type C/Hepatitis G Virus

Jack T. Stapleton

Professor, Medical Service, Iowa City VA Hospital and Department of Internal Medicine, University of Iowa. Iowa City, Iowa

Abstract

ABSTRACT

After hepatitis G virus (HGV) and GB virus type C (GBV-C) were independently discovered, it was determined that they were two isolates of the same virus. The HGV/GBV-C genome sequence and organization are closely related to hepatitis C virus. Although HGV/GBV-C infection is common and frequently persists in humans, infection has not been found to be associated with any known disease state. Because this virus is not associated with acute or chronic hepatitis, most people refer to it as GBV-C. GBV-C appears to grow in lymphocytes and not in hepatocytes, and presumably this is why the virus does not cause liver disease. Recent studies suggest that GBV-C infection in HIV-positive people is associated with prolonged survival. In vitro coinfection of human lymphocytes with GBV-C and HIV lead to decreased HIV replication. Further understanding of the mechanism(s) responsible for this interaction with HIV may provide novel approaches for treating HIV and AIDS.

KEYWORDS

GB virus - flavivirus - HCV

Volltext

Referenzen

REFERENCES

1 Deinhardt F, Holmes A W, Capps R B, Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med . 1967; 125 673-688
2 Parks W P, Melnick J L. Attempted isolation of hepatitis viruses in marmosets. J Infect Dis . 1969; 120 539-547
3 Tabor E, Seeff L B, Gerety R J. Lack of susceptibility of marmosets to human non-A, non-B hepatitis. J Infect Dis . 1979; 140 794-797
4 Tabor E, Peterson D A, April M, Seeff L B, Gerety R J. Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis. J Med Virol . 1980; 5 103-108
5 Simons J N, Pilot-Matias T J, Leary T P. et al . Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA . 1995; 92 3401-3405
6 Muerhoff A S, Leary T P, Simons J N. et al . Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol . 1995; 69 5621-5630
7 Linnen J, Wages J, Zhang-Keck Z-Y. et al . Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science . 1996; 271 505-508
8 Simons J N, Leary T P, Dawson G J. et al . Isolation of novel virus-like sequences associated with human hepatitis. Nat Med . 1995; 1 564-569
9 Leary T P, Muerhoff A S, Simons J N. et al . Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol . 1996; 48 60-67
10 Dickens T, Lemon SM.. GB virus C, hepatitis G virus, or human orphan flavivirus?. Hepatology . 1997; 25 1285-1286
11 Dawson G J, Schlauder G G, Pilot-Matias T J. et al . Prevalence studies of GB virus-C using reverse-transcriptase-polymerase chain reaction. J Med Virol . 1996; 50 97-103
12 Xiang J, Wunschmann S, Schmidt W N, Shao J, Stapleton J T. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol . 2000; 74 9125-9133
13 Lefrère J J, Roudot-Thoraval F, Roudot-Thoraval R. et al . GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals. J Med Virol . 1999; 59 32-37
14 Tillmann H L, Heiken H, Knapik-Botor A. et al . Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med . 2001; 345 715-724
15 Lau D T, Miller K D, Detmer J. et al . Hepatitis G virus and human immunodeficiency virus co-infection: response to interferon-alpha therapy. J Infect Dis . 1999; 180 1334-1337
16 Toyoda H, Takahashi I, Fukuda Y, Hayakawa K, Takamatsu J. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia. J Med Virol . 2000; 60 34-38
17 Masuko K, Mitsui T, Iwano K. et al . High prevalence of GB virus C in patients on maintenance hemodialysis. N Engl J Med . 1996; 334 1485-1490
18 Alter H J. G-pers creepers, where'd you get those papers?. <~>A reassessment of the literature on the hepatitis G virus. Transfusion . 1997; 37 569-572
19 Alter M J, Gallagher M, Morris T T. et al . Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med . 1997; 336 741-746
20 Alter H J, Nakatsuji Y, Melpolder J. et al . The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med . 1997; 336 747-754
21 Gutierrez R A, Dawson G J, Knigge M F. et al . Seroprevalence of GB virus C and persistence of RNA and antibody. J Med Virol . 1997; 53 167-173
22 Schaluder G G, Dawson G J, Simons J N. et al . Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol . 1995; 46 81-90
23 Pilot-Matias T J, Carrick R J, Coleman P F. et al . Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology . 1996; 225 282-292
24 Thomas D L, Vlahov D, Alter H J. et al . Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis . 1998; 177 539-542
25 Feucht H H, Zollner B, Polywka S. et al . Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology . 1997; 26 491-494
26 Heringlake S, Ockenga J, Tillmann H L. et al . GB virus C/ hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?. J Infect Dis . 1998; 177 1723-1726
27 Tacke M, Schmolke S, Schlueter V. et al . Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology . 1997; 26 1626-1633
28 Klinzman D, Katz L, George S L. et al .GBV-C prevalence in different populations suggests increased clearance with parenteral transmission. Oral presentation at the meeting on Viral Hepatitis and Liver Disease. April 8, 2003; Sydney, Australia
29 Devereux H, Sabin C A, Kinson Z. et al . Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients. J Med Virol . 1998; 56 316-320
30 Williams C M, Klinzman D, Yamashita T. et al .Persistent GBV-C virus type C (GBV-C) infection is associated with decreased risk of death in HIV-seroconvertors in the Multicenter AIDS Cohort Study (MACS). Oral presentation at the Conference on Retroviruses and Opportunistic Infections. February 13, 2003; Boston, MA
31 Jarvis L M, Davidson F, Hanely J P. et al . Infection with hepatitis G virus among recipients of plasma products. Lancet . 1996; 348 1352-1355
32 Stapleton J T. Hepatic and pancreatic dysfunction in HIV-infected individuals (in press). In: Swindells S, ed. 2002
33 Simons J N, Desai S M, Mushahwar I K. The GB viruses. Curr Top Microbiol Immunol . 2000; 242 341-375
34 Sarrazin C, Ruster B, Lee J-H. et al . Prospective follow-up of patients with GBV-C/HGV infection: specific mutational patterns, clinical outcome, and genetic diversity. J Med Virol . 2000; 62 191-198
35 Scallan M F, Clutterbuck D, Jarvis L M, Scott G R, Simmonds P. Sexual transmission of GB virus C/hepatitis G virus. J Med Virol . 1998; 55 203-208
36 Nerurkar V R, Chua P K, Hoffman P R. et al . High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission. J Med Virol . 1998; 56 123-127
37 Bourlet T, Guglielminotti C, Evrard M. et al . Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure. J Med Virol . 1999; 58 373-377
38 Hollingsworth R C, Minton E J, Fraser-Moodie C. et al . Hepatitis G infection: role in cryptogenic chronic liver disease and primary liver cell cancer in the UK. Trent Hepatitis C Virus Study Group. J Viral Hepat . 1998; 4 165-169
39 Xiang J, Wunschmann S, Diekema D J. et al . Effect of co-infection with GB virus C (hepatitis G virus) on survival among patients with HIV infection. N Engl J Med . 2001; 345 707-714
40 Kozal M J, Friedland G, Kyriakides T. et al .Prevalence of HIV and GBV-C co-infection and the likelihood of HIV genotypic resistance development. Abstract presented at the Retrovirus Conference. February 25, 2002; Seattle, WA
41 Stapleton J T, Xiang J, George S, Klinzman D. Evidence for delayed human immunodeficiency virus (HIV) disease progression in HIV-GB virus C co-infected individuals. In: Margolis H, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease London: International Medical Press 2002: 469-472
42 Lefrère J J, Sender A, Mercier B. et al . High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors. Transfusion . 2000; 40 602-607
43 Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet . 1995; 346 1131-1132
44 Heringlake S, Osterkamp S, Trautwein C. et al . Association between fulminant hepatic failure and a strain of GBV virus C. Lancet . 1996; 348 1626-1629
45 Tanaka E, Alter H J, Nakatsuji Y. et al . Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med . 1996; 125 740-743
46 Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan?. Lancet . 1996; 347 908
47 Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet . 1996; 347 1552
48 Kanda T, Yokosuka O, Ehata T. et al . Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Hepatology . 1997; 25 1261-1265
49 Rambusch E G, Wedemeyer H, Tillmann H L, Heringlake S, Manns M P. Significance of co-infection with hepatitis G virus for chronic hepatitis C-a review of the literature. Z Gastroenterol . 1998; 36 41-53
50 Fried M W, Khudyakov Y E, Smallwood G A. et al . Hepatitis G virus co-infection in liver transplant recipients with chronic hepatitis C and non-viral chronic liver disease. Hepatology . 1997; 25 1271-1275
51 Tillmann H L, Heringlake S, Trauwein C. et al . Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology . 1998; 28 379-384
52 Pessoa M G, Terrault N A, Ferrell L D. et al . Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology . 1997; 25 1266-1270
53 Hassoba H M, Pessoa M G, Terrault N A. et al . Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model. J Med Virol . 1998; 56 253-258
54 Brown K E, Tisdale J, Barrett A J, Dunbar C E, Young N S. Hepatitis-associated aplastic anemia. N Engl J Med . 1997; 336 1059-1064
55 Moriyama K, Okamura T, Nakano S. Hepatitis GB virus C genome in the serum of aplastic anaemia patients receiving frequent blood transfusions. Br J Haematol . 1997; 96 864-867
56 Kanda T, Yokosuka O, Imazeki F. et al . GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis. J Hepatol . 1997; 27 464-469
57 Kubo S, Nishiguchi S, Kuroki T. et al . Poor association of GBV-C viremia with hepatocellular carcinoma. J Hepatol . 1997; 27 91-95
58 Tagger A, Donato F, Ribero M L. et al . A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC Study. Hepatology . 1997; 26 1653-1657
59 Zignego A L, Giannini C, Gentilini P. et al . Could HGV infection be implicated in lymphomagenesis?. Br J Haematol . 1997; 98 778-779
60 Fargion S, Sampietro M, Fracanzani A L. et al . Hepatitis G virus in patients with porphyria cutanea tarda (PCT). J Hepatol . 1997; 26(Suppl) 207
61 Nagao Y, Sata M, Noguchi S. et al . GB virus infection in patients with oral cancer and oral lichen planus. J Oral Pathol Med . 1997; 26 138-141
62 Goodnough L T, Brecher M E, Kanter M H, Aubuchon J P. Medical progress: transfusion medicine (first of two parts)-blood transfusion. N Engl J Med . 1999; 340 438-447
63 Smith D B, Simmonds P, Frost S. et al . Phylogenetic analysis of GBV-C/hepatitis G virus. J Gen Virol . 2000; 81 769-780
64 Simons J N, Desai S M, Schultz D E, Lemon S M, Mushahwar I K. Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genomic organization. J Virol . 1996; 70 6126-6135
65 Xiang J, Klinzman D, McLinden J. et al . Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol . 1998; 72 2738-2744
66 Xiang J, Daniels K J, Soll D R. et al . Visualization and characterization of GB virus C (hepatitis G virus) particles: evidence for a nucleocapsid. J Viral Hepat . 1999; 6 S16-S22
67 Wunschmann S, Klinzman D, Medh J. et al . Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low density lipoprotein receptor. J Virol . 2000; 74 10055-10062
68 Agnello V, Abel G, Elfahal M, Knight G B, Zhang X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA . 1999; 96 12766-12771
69 Monazahian M, Bohme I, Bonk S. et al . Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol . 1999; 57 223-229
70 Thomssen R, Bonk S, Propfe C. et al . Association of hepatitis C virus in human sera with beta-lipoproteins. Med Microbiol Immunol . 1992; 181 293-300
71 Khudyakov Y E, Cong M-E, Bonafonte M-T. et al . Sequence variation within a nonstructural region of the hepatitis G virus genome. J Virol . 1997; 71 6875-6880
72 Belyaev A S, Chong S, Novikov A. et al . Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins. J Virol . 1998; 72 868-872
73 Saito S, Tanaka K, Kondo M. et al . Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells. Biochem Biophys Res Commun . 1997; 237 288-291
74 Sergi C, Jundt K, Seipp S. et al . The distribution of HBV, HCV, and HGV among livers with fulminant hepatic failure of different aetiology. J Hepatol . 1998; 29 861-871
75 Ikeda M, Sugiyama K, Mizutani T. et al . Hepatitis G virus replication in human cultured cells displaying susceptibility to hepatitis C virus infection. Biochem Biophys Res Commun . 1997; 235 505-508
76 Seipp S, Scheidel M, Hofmann W J. et al . Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines. J Hepatol . 1999; 30 570-579
77 Mellor J, Haydon G, Blair C. et al . Low level or absent in vitro replication of hepatitis C virus and hepatitis G virus/ GB virus C in peripheral blood mononuclear cells. J Gen Virol . 1998; 79 705-714
78 Laskus T, Radkowski M, Wang L F, Vargas H, Rakela J. Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR. J Virol . 1998; 72 3072-3075
79 Radkowski M, Kubicka J, Kisiel E. et al . Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood . 2000; 95 3986-3989
80 Pessoa M G, Terrault N A, Detmer J. et al . Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology . 1998; 27 877-880
81 Tucker T J, Smuts H EM, Eedes C. et al . Evidence that the GBV-C/hepatitits C virus is primarily a lymphotropic virus. J Med Virol . 2000; 61 52-58
82 George S L, Klinzman D, Xiang J, Stapleton J T. Different GBV-C Replication phenotypes in in vitro culture models. Presented at the Retrovirus Conference. February 25, 2002; Seattle, WA
83 Xiang J, Wunschmann S, Schmidt W N, Shao J, Stapleton J T. In vitro replication of a GB virus C infectious clone. In: Margolis H, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease London: International Medical Press 2002: 464-468
84 George S L, Gebhardt J, Klinzman D. et al . Hepatitis C virus (HCV) viremia in HIV-infected individuals with negative HCV antibody tests. J Acquir Immune Defic Syndr . 2002; 31 154-162
85 George S L, Klinzman D, Schmidt W N. et al .Antibody negative HCV infection in HIV positive individuals. In: Margolis H, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease London: International Medical Press 2002 : 357-361
86 Yeo A ET, Matsumoto A, Hisada M. et al . Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Ann Intern Med . 2000; 132 959-963
87 Rey D, Vidinic-Moularde J, Meyer P. et al . High prevalence of GB virus C/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis . 2000; 19 721-724
88 Tillmann H L, Manns M P. GB virus-C infection in patients infected with the human immunodeficiency virus. Antiviral Res . 2001; 52 83-90
89 George S L, Wunschmann S, McCoy J, Xiang J, Stapleton J T. Interactions between GB Virus Type C and HIV. Curr Infect Dis Rep . 2002; 4 550-558
90 Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus co-infection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr . 1998; 17 209-213
91 Sabin C A, Devereux H, Kinson Z. et al . Effect of co-infection with hepatitis G virus on HIV disease progression in hemophilic men. J Acquir Immune Defic Syndr . 1998; 19 546-547
92 Lefrère J J, Roudot-Thoraval F, Morand-Joubert L. et al . Carriage of GB Virus C/Hepatitis G Virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis . 1999; 179 783-789
93 Macalalad A R, Snydman D R. GB virus C and mortality from HIV infection. N Engl J Med . 2002; 346 377-379
94 Stapleton J T, Diekema D J, Xiang J. GB virus C and mortality from HIV infection. N Engl J Med . 2002; 346 377-379
95 Rodriguez B, Valdez H, Lederman M M. Effect of hepatitis G co-infection on response to antiretroviral treatment in HIV-infected patients. Presented at the 39th Infectious Diseases Society of America Meeting. 2001; San Francisco, CA. Abstract 698
96 Nunnari G, Nigro L, Palermo F. et al .Slower progression of HIV-1-infection in HGV/GB virus C co-infected individuals correlates with an intact T helper 1 cytokine profile. Presented at the Retrovirus Conference. 2002; Seattle, WA
97 Brust D, Jagannatha S, Herpin B. et al .Hepatitis G virus (HGV) infection does not prolong survival of patients with early-stage HIV disease: importance of baseline HIV viral load as a predictor of mortality. Presented at the XIV International AIDS Conference. 2002; Barcelona, Spain. WeOrC1378
98 Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS . 2002; 16 2482-2485
99 Fogeda M, Navas S, Martin J. et al . In vitro infection of human peripheral blood mononuclear cells by GB virus C/ hepatitis G virus. J Virol . 1999; 73 4052-4061
100 George S L, Stapleton J T, Stapleton J T. GBV-C replication in PBMC cultures occurs in B and T lymphocytes, and does not require T cell activation. Presented at the conference on Retroviruses and Opportunistic Infections. February 12, 2003; Boston, MA
101 Xiang J, George S L, Wuenschmann S, Klinzman D, Stapleton J T. GBV-C infection inhibits CCR5 and CXCR4 HIV strains, and alters chemokine and cytokine gene expression in PBMC cultures. Presented at the Conference on Retroviruses and Opportunistic Infections. February 12, 2003; Boston, MA
102 Mosier D E, Chisari F V. GB virus C and mortality from HIV infection. N Engl J Med . 2002; 346 377-379